1,5-benzodiazepines, a novel class of hepatitis C virus polymerase nonnucleoside inhibitors.
Nyanguile, O., Pauwels, F., Van den Broeck, W., Boutton, C.W., Quirynen, L., Ivens, T., van der Helm, L., Vandercruyssen, G., Mostmans, W., Delouvroy, F., Dehertogh, P., Cummings, M.D., Bonfanti, J.F., Simmen, K.A., Raboisson, P.(2008) Antimicrob Agents Chemother 52: 4420-4431
- PubMed: 18852280 
- DOI: 10.1128/AAC.00669-08
- Primary Citation of Related Structures:  
3CSO - PubMed Abstract: 
The exogenous control of hepatitis C virus (HCV) replication can be mediated through the inhibition of the RNA-dependent RNA polymerase (RdRp) activity of NS5B. Small-molecule inhibitors of NS5B include nucleoside and nonnucleoside analogs. Here, we report the discovery of a novel class of HCV polymerase nonnucleoside inhibitors, 1,5-benzodiazepines (1,5-BZDs), identified by high-throughput screening of a library of small molecules ...